Eden Research (LON:EDEN) Posts Quarterly Earnings Results

Eden Research (LON:EDEN) released its earnings results on Wednesday. The company reported GBX (0.36) earnings per share for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.

Eden Research Price Performance

Shares of LON EDEN opened at GBX 2.17 on Thursday. The business’s 50 day moving average price is GBX 2.72 and its two-hundred day moving average price is GBX 3.16. The company has a market cap of £17.43 million, a PE ratio of -4.90 and a beta of 1.57. The company has a quick ratio of 2.42, a current ratio of 2.25 and a debt-to-equity ratio of 1.43. Eden Research has a twelve month low of GBX 1.96 and a twelve month high of GBX 5.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.